These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36899075)
1. Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers. Hofmann G; Zierk J; Sobik B; Wotschofsky Z; Sembill S; Krumbholz M; Metzler M; Karow A Sci Rep; 2023 Mar; 13(1):4022. PubMed ID: 36899075 [TBL] [Abstract][Full Text] [Related]
2. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia. Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933 [TBL] [Abstract][Full Text] [Related]
3. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34 Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U Front Immunol; 2018; 9():1841. PubMed ID: 30154788 [TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130 [TBL] [Abstract][Full Text] [Related]
5. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Savani BN; Mielke S; Rezvani K; Montero A; Yong AS; Wish L; Superata J; Kurlander R; Singh A; Childs R; Barrett AJ Biol Blood Marrow Transplant; 2007 Oct; 13(10):1216-23. PubMed ID: 17889359 [TBL] [Abstract][Full Text] [Related]
6. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival. Koehl U; Bochennek K; Zimmermann SY; Lehrnbecher T; Sörensen J; Esser R; Andreas C; Kramm C; Grüttner HP; Falkenberg E; Orth A; Bader P; Schwabe D; Klingebiel T Bone Marrow Transplant; 2007 Mar; 39(5):269-78. PubMed ID: 17311085 [TBL] [Abstract][Full Text] [Related]
7. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients. Park BG; Park CJ; Jang S; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH Leuk Res; 2015 Dec; 39(12):1334-41. PubMed ID: 26422556 [TBL] [Abstract][Full Text] [Related]
8. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation. Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518 [TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection. El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245 [TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930 [TBL] [Abstract][Full Text] [Related]
11. Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients. Bhatt ST; Bednarski JJ; Berg J; Trinkaus K; Murray L; Hayashi R; Schulz G; Hente M; Grimley M; Chan KW; Kamani N; Jacobsohn D; Nieder M; Hale G; Yu L; Adams R; Dalal J; Pulsipher MA; Haut P; Chaudhury S; Davis J; Jaroscak J; Andreansky M; Willert J; Shenoy S Biol Blood Marrow Transplant; 2019 Mar; 25(3):556-561. PubMed ID: 30321596 [TBL] [Abstract][Full Text] [Related]
12. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640 [TBL] [Abstract][Full Text] [Related]
13. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089 [TBL] [Abstract][Full Text] [Related]
14. Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia. Veys P; Wynn RF; Ahn KW; Samarasinghe S; He W; Bonney D; Craddock J; Cornish J; Davies SM; Dvorak CC; Duerst RE; Gross TG; Kapoor N; Kitko C; Krance RA; Leung W; Lewis VA; Steward C; Wagner JE; Carpenter PA; Eapen M Blood; 2012 Jun; 119(25):6155-61. PubMed ID: 22573402 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of immune reconstitution at early stage after unmanipulated haploidentical stem cell transplantation between high- and standard- risk Philadelphia chromosome- negative acute lymphoblastic leukemia patients in CR1]. Bian ZL; Chang YJ; Xu LP; Wang Y; Zhang XH; Liu KY; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):650-5. PubMed ID: 27587244 [TBL] [Abstract][Full Text] [Related]
17. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402). Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885 [TBL] [Abstract][Full Text] [Related]